Verition Fund Management’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-141,832
Closed -$1.25M 3991
2025
Q3
$1.25M Buy
+141,832
New +$1.06M 0.01% 2349
2025
Q2
Sell
-11,565
Closed -$69.7K 3892
2025
Q1
$69.7K Buy
+11,565
New +$70.7K ﹤0.01% 3179
2022
Q4
Sell
-2,329
Closed -$24K 2791
2022
Q3
$24K Buy
2,329
+691
+42% +$9.64K ﹤0.01% 2770
2022
Q2
$23K Buy
+1,638
New +$26.1K ﹤0.01% 2209
2018
Q2
Sell
-988
Closed -$35K 1344
2018
Q1
$35K Buy
+988
New +$38.3K ﹤0.01% 1089

Other funds holding VSTM

Verition Fund Management's VSTM Position: Q4 2025 in Review

Verition Fund Management sold out of Verastem (VSTM) in Q4 2025, closing a stake of 141,832 shares — an estimated $1.25M sold.

Verition Fund Management first reported a position in VSTM in Q1 2018 and held it in 5 quarters. The position peaked at $1.25M in Q3 2025. 142 funds tracked by Wall St. Rank hold VSTM as of Q4 2025.

  • Verition Fund Management reported no remaining Verastem position as of Q4 2025 after selling out during the quarter.
  • Verition Fund Management sold 141,832 Verastem shares in Q4 2025, an estimated $1.25M.
  • Verition Fund Management first reported a position in Verastem in Q1 2018 and held it in 5 quarters.
  • Verition Fund Management's Verastem position peaked at $1.25M in Q3 2025.
  • 142 funds tracked by Wall St. Rank held Verastem as of Q4 2025.

Based on Verition Fund Management's 13F filing for Q4 2025, filed 13 Feb 2026.